Bernardsville, NJ, United States of America

Ishani Savant Landry

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ishani Savant Landry. Retrieved from https://idiyas.com/inventor/ishani-savant-landry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ishani Savant Landry: Innovator in Pharmaceutical Composition

Introduction

Ishani Savant Landry is a notable inventor based in Bernardsville, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on PDE9 inhibitors. Her dedication to research and development has positioned her as a key figure in her industry.

Latest Patents

Ishani holds a patent for a pharmaceutical composition comprising a PDE9 inhibitor. The specific compound she has developed is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one or pharmaceutically acceptable salts thereof. This invention showcases her expertise and commitment to advancing medical treatments.

Career Highlights

Ishani is currently employed at Eisai R&D Management Co., Ltd., where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to her company's success but has also had a broader impact on the healthcare industry.

Collaborations

Ishani has collaborated with esteemed colleagues, including Edgar Schuck and Robert Lai. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Ishani Savant Landry is a pioneering inventor whose work in pharmaceutical compositions is making a difference in the field. Her contributions, particularly in developing PDE9 inhibitors, highlight her role as a leader in innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…